Integrating Advanced Molecular Technologies to Evaluate Hematologic Malignancies

Join us for either session

• Date: July 16, 2025 (Wednesday)
• Time: 8:00 AM PDT | 4.00 PM BST | 5:00 PM CEST

• Date: July 17, 2025 (Thursday)
• Time: 9.30 AM IST | 12.00 PM SGT | 1:00 PM KST/ JST | 2:00 PM AEST

Join us for a practical discussion on leveraging complementary molecular technologies to improve hematologic malignancy testing. Hear how a leading lab is applying integrated approaches to enhance speed to results, accuracy, and the detection of key variants across a range of blood cancers.

Learning objectives

1. How combining NGS, dPCR, and microarray enhances detection of mutations, copy number variants, and residual disease markers.
2. The impact of integrated workflows on turnaround time, sensitivity, and laboratory efficiency.
3. Practical considerations for implementing advanced molecular testing in a laboratory setting.
4. Real-world clinical research examples of applying these tools to myeloid and lymphoid malignancies, including CLL and lymphoma.